Regeneration of segmental defects in metatarsus of sheep with vascularized and customized 3D-printed calcium phosphate scaffolds by Vidal, Luciano et al.
1Scientific RepoRtS |         (2020) 10:7068  | https://doi.org/10.1038/s41598-020-63742-w
www.nature.com/scientificreports
Regeneration of segmental 
defects in metatarsus of sheep 
with vascularized and customized 
3D-printed calcium phosphate 
scaffolds
Luciano Vidal  1, carina Kampleitner2,10, Stéphanie Krissian3,10, Meadhbh Á Brennan1,4, 
oskar Hoffmann2, Yago Raymond  5,6,7, Yassine Maazouz5,6,7, Maria-Pau Ginebra5,6,8, 
philippe Rosset1,3,9 & pierre Layrolle  1 ✉
Although autografts are considered to be the gold standard treatment for reconstruction of large bone 
defects resulting from trauma or diseases, donor site morbidity and limited availability restrict their 
use. Successful bone repair also depends on sufficient vascularization and to address this challenge, 
novel strategies focus on the development of vascularized biomaterial scaffolds. This pilot study aimed 
to investigate the feasibility of regenerating large bone defects in sheep using 3D-printed customized 
calcium phosphate scaffolds with or without surgical vascularization. Pre-operative computed 
tomography scans were performed to visualize the metatarsus and vasculature and to fabricate 
customized scaffolds and surgical guides by 3D printing. Critical-sized segmental defects created in the 
mid-diaphyseal region of the metatarsus were either left empty or treated with the 3D scaffold alone or 
in combination with an axial vascular pedicle. Bone regeneration was evaluated 1, 2 and 3 months post-
implantation. After 3 months, the untreated defect remained non-bridged while the 3D scaffold guided 
bone regeneration. the presence of the vascular pedicle further enhanced bone formation. Histology 
confirmed bone growth inside the porous 3D scaffolds with or without vascular pedicle inclusion. 
Taken together, this pilot study demonstrated the feasibility of precised pre-surgical planning and 
reconstruction of large bone defects with 3D-printed personalized scaffolds.
Bone is a dynamic tissue that possesses the intrinsic capacity to heal within 6–8 weeks after immobilization of a 
fracture. However, there are some conditions in which bone regeneration is delayed, compromised or beyond the 
physiological healing potential1,2. Notably, the successful repair of large bone defects caused by trauma, tumor 
resection or disease remains a clinical challenge for orthopedic and plastic surgeons and often requires additional 
treatments. Autologous bone grafting is still considered the gold standard treatment due to its osteoconduc-
tive, osteoinductive and osteogenic properties. This procedure necessitates harvesting the patient’s own bone 
and subsequently transplanting it to the defect site. Bone can be taken from several areas e.g., iliac crest or fibula, 
depending on the severity and amount needed for reconstruction of the defect. Nevertheless, the amount of 
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bone is limited and the procedure adds morbidity at the harvesting site. Therefore, this surgical procedure is 
often associated with complications such as infection, hematoma, postoperative pain, and muscular and neural 
damage. Transplantation of vascularized bone also requires complex microsurgery to adapt to both the local vas-
culature and skeleton3,4. Other procedures for large bone regeneration are the Masquelet’s induced membrane, the 
Illizarov’s distraction or advanced therapies with bone morphogenetic proteins or culture expanded bone marrow 
mesenchymal stem cells. However, these alternatives have inherent disadvantages including morbidity, surgical 
procedures, costs and safety concerns5–10.
For several decades, researchers and clinicians have attempted to develop a safe and effective alternative to 
autologous bone grafting for the regeneration of large bone defects. Among them, synthetic calcium phosphate 
biomaterials that resemble the inorganic phase of bone have proven to be biocompatible and osteoconductive. 
Most commercially available calcium phosphate-based bone substitutes are composed of either hydroxyapatite 
(HA), β-tricalcium phosphate (β-TCP), or a mixture of both, termed biphasic calcium phosphate (BCP). They are 
made at high sintering temperatures and are generally used as granules or porous blocks. Although these bioce-
ramics share some compositional similarities with bone minerals, the conventional processes employed to man-
ufacture them limit the possibilities to tune their pore architecture, often lacking interconnections and hindering 
their osteogenic potential to support healing of large bone defects11–14. Recently, biomimetic calcium phosphates 
consisting of calcium-deficient hydroxyapatite (CDHA) that can be manufactured at ambient temperature have 
been developed and have shown to have enhanced surface area and promote osteogenic differentiation and bone 
healing compared to their sintered counterparts15,16.
Three-dimensional (3D) printing permits the production of customized scaffolds and surgical guides based 
on the patient’s anatomy from computed tomography (CT) scans that are essential for surgical planning, precise 
resection and accurate bone reconstruction. CDHA inks have been developed to manufacture 3D scaffolds using 
a layer-by-layer deposition, also known as 3D-microextrusion. The advantages of this 3D-printed biomaterial are 
the structural and compositional features that closely resemble the mineral phase of bone compared with conven-
tional bioceramics, and the ambient temperature manufacturing process that offers the possibility of reinforcing 
the structure with polymers or incorporate drugs. Furthermore, 3D printing allows accurate control of construct 
shape and their interconnected porosity favoring body fluids permeability, cell invasion, vascularization and bone 
ingrowth, making these 3D scaffolds promising therapeutic alternatives to treat large bone defects15,17–19.
Another essential aspect of bone transplantation is vascularization. The development of a vascular network 
is crucial for the exchange of nutrients, minerals and soluble molecules which are important during the repair 
process and ensure the viability of the bone graft. Lack of vascularization causes inner tissue necrosis and results 
in graft failure, particularly in large bone defects. In this respect, the interconnected porosity of the 3D scaffold 
facilitates the formation of new blood vessels throughout the entire material. Recent studies have attempted to 
enhance vascularization by either pre-vascularizing the construct before implantation or by adding angiogenic 
growth factors such as vascular endothelial growth factor (VEGF) or platelet-derived growth factor (PDGF) dur-
ing the grafting procedure. Although these approaches showed promising results, novel strategies are required to 
further enable vascularization, in particular for large bone defects12,20–22.
This work aims to investigate the feasibility of a one-step surgical skeletal reconstruction and regeneration of 
large bone defects in a relevant pre-clinical animal model. We hypothesize that the application of a 3D-printed 
CDHA scaffold with pre-defined shape and interconnected porosity combined with a local and axial vascular 
pedicle will improve bone regeneration.
Results
Pre-operative computed tomography (CT) for designing customized surgical guides and 3D 
scaffolds. One month before surgery, a CT angioscan of the metatarsus of sheep was performed to visualize 
the local vasculature and bone (Fig. 1a). This 3D reconstruction shows that three main blood vessels were present 
along the metatarsal bone, while the lateral plantar artery was selected for axial vasculature of the 3D scaffolds. As 
shown in Fig. 1b, a customized surgical guide was designed to assist for the creation of a critical-sized segmental 
diaphyseal defect (length: 35 mm) in the metatarsus of sheep, and for drilling the holes for the osteosynthesis 
screws to fix the plate that stabilizes the fracture. This pre-operative CT scan was also used to manufacture a 
customized 3D scaffold with interconnected porosity that fitted the defect and a groove to incorporate the axial 
vascular pedicle.
Physicochemical characterization of the 3D-printed calcium phosphate scaffolds. As shown 
in Fig. 2, the 3D scaffolds were designed with interconnected porosity and a groove to accommodate the axial 
vascular pedicle. The 3D scaffolds were then printed by using a robocasting device with a syringe containing 
the calcium phosphate paste coupled to a nozzle. A vascular plug with rounded edges was used for retaining the 
axial vascular pedicle inside the 3D scaffold (Supplementary Fig. 1). The porosity had an orthogonal rectilinear 
pattern with alternate crisscrossed layers rotated 90° relative to the previous layer creating an interconnected 
pore network mesh. The microstructure of the 3D scaffolds, as observed by scanning electron microscopy (SEM), 
consisted of an entangled network of nanosized needle-like hydroxyapatite crystals.
The physicochemical characteristics of the 3D scaffolds are reported in Table 1. After setting, the 3D scaffolds 
were composed of 80.3% of CDHA, 18.7% β-TCP and no presence of its alpha polymorph (α-TCP). The main 
body presented an inter-strand gap of 703.2 ± 23.9 µm and a filament width of 489.7 ± 9.7 µm in line with the 
410 µm-nozzle used for 3D printing, whereas the scaffolds printed with the 311 µm-nozzle-setup presented an 
inter-filament separation of 529.4 ± 25.3 µm and a filament width of 364.2 ± 11.9 µm. According to the mercury 
intrusion porosimetry (MIP) analysis, the scaffold presented 81.03% of open porosity of which 59.52% corre-
spond to pores with entrance sizes larger than 10 µm (macro-pores) and the remaining 21.52% corresponding to 
pores with entrance sizes smaller than 10 µm (micro/nano-pores). The specific surface area of the 3D scaffolds 
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was 22.1 m2/g in agreement with their microstructure. The uniaxial compression testing assays resulted in similar 
values for both conditions: the scaffolds printed with the 410 µm-nozzle-setup and 311 µm-nozzle-setup had an 
ultimate compressive strength of 2.10 ± 0.30 and 2.45 ± 0.53 MPa respectively.
Animal welfare and surgical procedure. All sheep survived the operative intervention without any early 
or long-term post-operative complications. Figure 3 demonstrates the surgical procedure using the pre-designed 
customized surgical guide and the 3D-printed scaffold. The application of the surgical guides supported the crea-
tion of a segmental critical-sized defect of 35 mm at the mid-diaphyseal level of the metatarsal bone and directed 
the drilling for the osteosynthesis plate. This controlled drilling allowed an accurate positioning during the per-
foration and avoided damage to the surrounding soft tissues. In addition, they helped to maintain the reproduc-
ibility in all the procedures. The lateral plantar artery (Arteria plantaris lateralis) that was isolated and passed 
through the 3D-printed scaffold to improve vascularization (3D scaffold + pedicle group) is shown in Fig. 3d. 
Figure 3e indicates identical anatomical shapes of the customized 3D-printed calcium phosphate scaffolds made 
by reverse engineering from CT scans compared to the bone resected at the day of surgery. The final reconstruc-
tion with the axial vascular pedicle passing through the anatomical 3D scaffold held by the fixation plate and 
screws is illustrated in Fig. 3f.
In vivo evaluation of 3D-printed calcium phosphate scaffolds. To study the ability of the scaffold 
to regenerate a large bone defect, bone repair was examined by in vivo CT scans over a healing period of 3 
months (day 0, 30, 60 and 90). As shown in Fig. 4, some bone regeneration occurred from the edges of the left 
empty defect on the side opposite to the osteosynthesis plate as early as D30. It indicated the endogenous healing 
potential of the mid-diaphyseal defect created in the metatarsus of sheep. In contrast, the defect filled with the 
3D-printed scaffold and the 3D-printed scaffold combined with the vascular pedicle showed enhanced bone for-
mation over the 3-month healing period. The scaffolds appeared well-integrated into the defect and surrounded 
by newly formed bone tissue. The origin of the bone regrowth was similar to that of the empty defect group and 
predominantly started from the external lateral side, opposite to the osteosynthesis plate. To monitor and control 
the durability of the vascular pedicle and vascular patency, angioscans were conducted by injecting an iodine con-
trast agent during the CT scan at day 30, 60 and 90. The vascular patency of the vascularized 3D-printed scaffold 
group was maintained for the 3 months of the study (Supplementary Fig. 2).
Micro-computed CT (microCT) scans calculations confirmed that the 3D scaffold before implantation had 
a rectangular interconnected porosity with a material volume/total volume (MV/TV) of 34.4% (n = 1), giving 
a macroporosity of 65.6%, in good agreement with the macroporosity of 59.5% measured by MIP (Fig. 5 and 
Table 1). Additionally, ex vivo high-resolution microCT was performed at the endpoint of the study (day 90) 
(Fig. 5). The left empty metatarsal defect had limited bone regeneration with a BV/TV value of 8.7% (n = 1). In 
contrast, the metatarsal defects filled with the customized 3D scaffolds and a fortiori in combination with the 
vascular pedicle showed a higher bone content, with BV + MV/TV values of 48.2% (n = 1) and 61.7% (n = 1), 
respectively.
As illustrated in Fig. 6, the histological evaluation corroborated the CT and microCT findings. The empty 
defect was mainly filled with fibrous tissue and demonstrated limited bone tissue formation from the defect 
edges, whereas metatarsal bone defects filled with a customized 3D-printed scaffold or the 3D-printed scaffold 
combined with the axial vascular pedicle demonstrated bone ingrowth into the 3D structure of the biomaterial. 
Figure 1. Design of the surgical cutting guide for the creation of a segmental mid-diaphyseal defect and the 
customized 3D scaffold. (a) Pre-operative CT scans were taken one month before surgery and 3D reconstructed. 
The image visualizes the metatarsal bone and the local vasculature. (b) Schematic diagram demonstrates the 
operating principle of the surgical guide and the filling of the bone defect (35 mm in length) with a customized 
3D scaffold with a groove for axial vascularization.
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At higher magnification, bone tissue containing osteocytes was present in contact with the 3D scaffold material. 
Osteocytes were more prevalent in the 3D-printed scaffold in combination with a vascular pedicle, indicating the 
formation of mature bone tissue in this latter group.
Discussion
Bone is the second most transplanted tissue after blood transfusion. Vascularization of the transplanted bone 
graft is essential for favorable clinical outcomes. Indeed, bone cells are located near blood vessels to ensure access 
to oxygen and to receive the necessary nutrients to regenerate tissues. It has been shown that with a sufficient 
amount of vascularization these bone cells can differentiate into osteocytes and thus regenerate bone tissue23–25. 
However, the current transplantation of vascularized bone requires complex microsurgery to reconnect vascula-
ture and to fit the anatomy of a defect, as well as adding morbidity at the harvesting site.
Figure 2. Fabrication and structure of a 3D-printed customized calcium phosphate scaffold. (a–c) Design and 
printing of a calcium phosphate scaffold by 3D-microextrusion. (d–i) Optical and scanning SEM images of the 
3D-printed scaffolds. Images were taken at different levels of magnification to visualize the structure and surface 
of the material.
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Vascular plug printed 
with 311 µm-nozzle
Trapezoid (L × 
H): 30  × 8 364.2 ± 11.9 529.4 ± 25.3 2.45 ± 0.53
Table 1. Physicochemical properties of the 3D scaffolds.
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Tissue engineering is potentially a promising alternative to autologous vascularized bone grafting for the 
reconstruction of large skeletal defects26–29. Numerous pre-clinical studies have demonstrated that the combi-
nation of mesenchymal stem cells (MSCs) with BCP biomaterials can induce bone formation and facilitate the 
healing of critical size defects30–33. Some clinical trials have demonstrated the feasibility of amplifying autologous 
MSCs in culture from a bone marrow sample and associating them with BCP biomaterial to regenerate unconsol-
idated fractures or small defects8,34. However, these tissue engineering techniques do not yet allow the regenera-
tion of large bone defects due to lack of adequate vascularization inhibiting cell survival and bone healing35,36. In 
this context, several teams have proposed the pre-vascularization of the bone filling material by implantation in 
an ectopic site before transplanting it into the defect to be reconstructed. Proof of concept has been demonstrated 
at the pre-clinical level by ectopic implantation in the ewe of a chamber containing the BCP biomaterial and 
an arteriovenous fistula (vascular loop). After 6 and 12 weeks of implantation, abundant microvasculature was 
observed in the chamber contents37–42. Large defects at the mandibular level have been successfully reconstructed 
in a few patients using this technique of transplanting a pre-vascularized biomaterial from an intramuscular 
site43,44. In these studies, the pre-vascularization of the biomaterial appears to dominate for cell survival and bone 
regeneration. Recently, Charbonnier et al. published a new arteriovenous bundle technique study enclosing a 
vascular pedicle, just the vein, passing centrally through a 3D-printed calcium phosphate scaffold45.
To our knowledge, our contribution is the first work in which, a pre-surgical CT angioscan allowed to create 
a truly personalized biomaterial scaffold that has the same anatomical shape as the defect. Moreover, with the 
pre-surgical CT angioscan, we were able to study the vasculature in the defect area to be reconstructed, allowing 
us to evaluate the possibility of isolating a pedicle composed of a peripheral artery and an adjacent vein. This 
pedicle was dissected from the surrounding tissues and passed through the implantable 3D-printed scaffold in 
order to provide vascularization without adding laborious microsurgery. This pilot study in sheep demonstrates 
the feasibility of fabricating customized 3D scaffolds and surgical guides based on CT scans that are essential 
for surgical planning, precise resection and accurate anatomical fitting of the 3D scaffold with anatomy. It is 
important to emphasize that in our work we performed a personalized large bone defect reconstruction with a 
3D-printed scaffold associated with a local vascular pedicle in a one-step surgery. Furthermore, 3D printing did 
not only allow control over the shape of the 3D scaffolds in order to accurately fit the anatomy of defects, but also 
permitted the design and production of an interconnected porosity favorable for body fluid permeability, vascu-
lature and bone ingrowth.
Some limitations of the current pilot study include firstly that some bone tissue regeneration was observed in 
the empty defect that has been previously described as a critical size bone defect37. We consider that this regener-
ated bone tissue was developed from the vascularized membrane that is constituted around the metatarsal bone 
and in the subcutaneous tissue which was not resected in this first study. To investigate this, we resected this 
membrane and our empty defect did not regenerate any bone tissue during the first 3 months (Supplementary 
Fig. 3). Secondly, the 3D scaffolds, even though they supported bone ingrowth, had insufficient mechanical prop-
erties in comparison with those of native bone tissue. It will be necessary to provide better mechanical reinforce-
ment, through for example, the addition of polymers. Although feasibility is demonstrated in a clinically relevant 
large animal model, this is a pilot study with only one animal per group, limiting statistical comparison. A further 
study in a larger population of animals is needed to assess the efficacy of this innovative approach and to compare 
bone regeneration and vascularization with or without an axial vascular pedicle in the 3D scaffolds.
To conclude, this pilot study that used pre-operative medical imaging, 3D printing of customized surgi-
cal guides and 3D scaffolds with a local and axial vascularization, might constitute a new approach for bone 
Figure 3. Creation of a critical sized segmental defect in sheep. Photographs of the surgical steps showing (a) 
the metatarsal bone, (b) the surgical guide used to create the bone defect, (c) the creation of a mid-diaphyseal 
segmental defect measuring 35 mm in the metatarsal bone, (d) the vascular pedicle used for the axial 
vascularization to the 3D-printed scaffold, (e) the customized shape of the 3D-printed scaffold and (f) the final 
result with the osteosynthesis plate fixation.
6Scientific RepoRtS |         (2020) 10:7068  | https://doi.org/10.1038/s41598-020-63742-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
regeneration with a synthetic bone graft substitute. This treatment strategy will potentially mimic the currently 
most employed autologous technique in the reconstruction of large bone defects, the fibula flap, but without the 
generation of a second surgical site and associated disadvantages.
Methods
ethical approval. Ethical approval for animal experimentation was obtained from the local ethics committee 
(Comité d’ethique en experimentation animale Val de Loire, CEEA19, France, ref. number 9235) and the French 
Ministry of Superior Education, Research and Innovation on February 28, 2018, by following the European 
Guidelines for Animal Care Directive 2010/63/EU.
Animals. The animal study was performed at the CIRE platform (agreement number: A371754; INRA, 
Nouzilly, France) that is fully equipped with an operating theatre, housing and medical imaging.
The 3-year old female Ile de France sheep (average weight of 65 kg) were supplied from the INRA breeder and 
were housed in boxes at the experimental facility. The animals were fed with straw and received water ad libitum. 
The animals were acclimated for a minimum of 2 weeks prior to the first intervention.
Figure 4. 3D bone reconstructions of metatarsal defects in sheep. CT scans are shown post-surgery (D0) and 
after 30, 60 and 90 days (D30, D60, D90) of healing. Treatment groups included the empty defect (control), a 
defect filled with the 3D-printed scaffold (Defect 3D), and a defect treated with the 3D-printed scaffold and the 
axial vascular pedicle (Defect 3D + P) (n = 1).
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Pre-operative computed tomography (CT). One month before surgery, the sheep were placed under 
general anesthesia by intravenous injection of ketamine (20 mg/kg, Kétamidor®, Axience, France) and xylazine 
(0.05 mg/kg, Rompun® 2%, Bayer, France). Animals were intubated and put under gaseous relay with 3% iso-
flurane (Isoflurin®, Axience, France) carried by 100% oxygen. The sheep was then placed in the right lateral 
decubitus position on the CT scanner table (Dual-source 64-slice spiral Somatom®, Siemens, France) with the 
left limb immobilized. Acquisition of the bone metatarsus on the left leg was performed at 300 mAs and 140 kV 
with a section of 0.6 mm generating 748 DICOM images in approximately 15 s. To visualize the vasculature, 80 ml 
of iodine contrast agent (350 mg I/ml; Omnipaque™, GE Healthcare, France) was injected in the jugular vein via 
a catheter (5 ml/s). Acquisitions were performed at 80, 120, 140 and 160 s post-injection of the contrast agent. CT 
scans were reconstructed and analyzed by using the imaging software syngo.via, (Siemens, France).
Design and fabrication of customized surgical guides using 3D printing. The customized surgical 
guide was designed to assist for the creation of a critical-sized segmental diaphyseal defect (length: 35 mm) in 
the metatarsus of sheep, and for drilling the holes for the osteosynthesis screws to fix the plate that stabilizes the 
fracture. Its main objective was to hold precisely the surgical oscillating blade and the drilling bur. To fabricate the 
surgical guide, DICOM images from the pre-operative CT scans of the metatarsi and the titanium osteosynthesis 
plates (LCP 3.5, 7 holes, L98 mm, Johnson & Johnson Medical) were converted to 3D stereolithography (STL) 
files using an open-source software (3D Slicer). Thereafter, the surgical guide was planned in the CAD program 
(Cinema 4D, Maxon, Germany). A phantom of the 3D scaffold and the metatarsus were produced in the same 
manner to examine the anatomical shape and size of the design (Fig. 1). The STL files of the different components 
Figure 5. MicroCT images of treated and untreated segmental defects in sheep. (a) MicroCT 3D 
reconstructions of metatarsal defects in sheep 90 days post-surgery. Images are presented for the scaffold before 
implantation (3D Scaffold), empty defect, defect filled with the 3D-printed scaffold (Defect 3D) and the defect 
filled with the 3D-printed scaffold associated with a vascular pedicle (Defect 3D + P). (b) Percentage of bone 
volume + material volume/total volume (BV + MV/TV) for the different treatment groups. The percentage 
of BV + MV/TV was calculated in the area of interest and compared to the microCT of the 3D scaffold taken 
before implantation (n = 1).
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(customized surgical guide, 3D scaffold and metatarsus) were translated into a printable g-code (3D printing 
software, Ultimaker Cura 3.0, Ultimaker, The Netherlands). The customized surgical guide was printed with 
nylon filament (2.85 ± 0.05 mm, Ultimaker) that sustained autoclave sterilization using a commercial 3D printer 
(Ultimaker 3 extended, Ultimaker). The metatarsus and 3D scaffold were printed with thermoplastic poly-lactic 
acid (PLA, 2.85 ± 0.10 mm, Ultimaker) in order to verify anatomical precision fitting to anatomy prior to surgery.
3D printing of the customized calcium phosphate scaffolds. The customized 3D calcium phosphate 
scaffolds (MimetikOss 3D, Mimetis Biomaterials S.L., Spain) were designed by reverse engineering from CT 
scans of the metatarsus of sheep and fabricated by robocasting, also known as direct ink writing, as previously 
published15,17. Briefly, a CDHA self-setting ink was prepared by mixing 35 wt% aqueous solution of poloxamer 
407 (P2443 – Pluronic, F-127, Sigma-Aldrich, Missouri, USA) and α-TCP (Innotere GmbH, Radebeul, Germany) 
powder at a ratio of 0.5 g/g. 3D scaffolds were printed by using a robocasting device (Heavy Duty Paste Extruder, 
BCN3D Technologies, Barcelona, Spain) with a syringe (Optimum® Syringe, Nordson EFD, U.S.A) contain-
ing the paste coupled to a tapered dispensing tip (SmoothFlow Tapered Tips, Nordson EFD) mounted on the 
machine. The 3D scaffold consisted of a two-part assembly as displayed in Supplementary Figure 1. The main 
body was a cylinder (length: 35 mm, diameter: 15–17 mm) with a central groove of 5 mm in width and 7 mm 
in depth for passing through the axial vascular pedicle. A vascular plug (length: 30 mm, height: 8 mm) with 
rounded edges was used for retaining the vascular pedicle inside the 3D scaffold. The geometry of the pores 
had an orthogonal rectilinear pattern with alternate crisscrossed layers rotated 90° relative to the previous layer 
creating an interconnected pore network mesh. Two different printing setups were defined for the two parts of 
the assembly. For the main body, we used a nozzle diameter of 410 µm (410 µm-nozzle-setup, 22 gauge) and for 
the vascular plug, a nozzle diameter of 311 µm (311 µm-nozzle-setup, 24 gauge). The filament width was set to 
370 µm and 490 µm respectively. The printing process was followed by a hydrothermal treatment for hardening 
as described elsewhere46. Subsequently, the samples were packaged in a double sterilization pouch and sterilized 
by autoclaving.
The dimensions of the customized 3D scaffolds, strand width and height and pore size in the X/Y plane and 
in the Z direction were measured with the combination of an optical microscopy (Luxeo 4D Digital Stereozoom 
Microscope, Labomed Europe, Capelle aan den Ijssel, The Netherlands) and an image analysis software (Fiji, 
ImageJ) as previously described46. A total of 20 measurements on 3 different samples of each printing setup 
were carried out. The microstructure of the scaffold was observed by SEM (Phenom XL, Phenom-World B.V., 
ThermoFisher Scientific, Eindhoven, The Netherlands). The phase composition of the scaffolds was assessed by 
X-ray diffraction (D8 Advance, Bruker, MA, USA) The inter-strand porosity distribution (range from 0.006 to 
100 µm) was measured by mercury intrusion porosimetry (MIP) (AutoPore IV Micromeritics, GA, USA). This 
technique was combined with helium psychometry (AccuPyc 1330, Micromeritics, GA, USA) and apparent den-
sity measurements, as described elsewhere47, in order to obtain an analysis of the porosity percentages in the 
scaffolds. The mechanical properties (ultimate compressive strength) were investigated using a universal testing 
machine (Bionx, MTS systems, USA). Details on the physicochemical analyses are reported in the supplementary 
methods.
Figure 6. Histological evaluation of bone repair. Representative undecalcified histological thin ground sections 
were prepared in the longitudinal plane and stained with Levai-Laczko dye 90 days post-surgery (n = 1). 
Photomicrographs are presented at three different magnifications. The black asterisk denotes the host bone (old 
bone) stained in light purple, whereas the black arrow demonstrates newly formed bone tissue visible in dark 
purple. The white asterisk highlights the 3D scaffold (n = 1).
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Critical-sized defects in sheep metatarsus. In this pilot study, three Ile de France sheep were deprived 
of food 24 hours before anesthesia. The technique used for creating a segmental defect in the metatarsus was 
according to a validated and previously described experimental model48. Briefly, the animals were anesthetized 
and treated with morphine hydrochloride (0.3 mg/kg, CDM Lavoisier, France) and oxytetracyline (20 mg/kg, 
Tenaline® LA, Ceva, France) for analgesia and antibiotic prophylaxis. During the surgical procedure, general 
anesthesia was maintained by orotracheal intubation and inhalation of 3% isoflurane in oxygen. The heart and 
breathing rates were continuously monitored. After shaving and disinfecting the surgical site, a longitudinal inci-
sion was made to expose the medial surface of the left metatarsus. The customized, sterile surgical guide was posi-
tioned on the medial surface of the long bone and a surgical saw was inserted. A segmental critical-sized defect 
of 35 mm in length was created under constant saline irrigation to remove bone debris and prevent overheating. 
The defect was either left empty, treated with a customized 3D-printed scaffold alone or in combination with a 
vascular pedicle passing through. For the group that was only treated with the 3D-printed scaffold, the vascular 
plug was inserted into the main body of the scaffold and subsequently implanted. For the vascularized group, the 
pedicle was positioned in the center of the 3D scaffold and closed up with the vascular plug without performing 
vascular compression. The vascular pedicles in the non-vascularized group and in the empty defect retained 
in the natural anatomical position. Afterwards, the metatarsus was stabilized by using a seven-hole dynamic 
compression plate (LCP 3.5 L98, Depuy Synthes, Johnson & Johnson Medical, France) and four head-locking 
screws (diameter: 3.5 mm, length: 20 mm). The holes for the osteosynthesis screws were made by drilling them 
at appropriate positions with the surgical guide. To close the wound, subcutaneous tissues and skin were sutured 
in separate layers with resorbable sutures (Optime® 4/0, Péters Medical, France). The limb was immobilized 
using a resin cast extending from nail to tibia that supported the weight with a splint for the entire period of the 
study. The sheep were allowed to bear weight immediately after the surgery. Post-operative pain was managed by 
administration of flunixine (1.5 mg/kg, Finadyne®, MSD Santé Animale, France). The animals were monitored 
by the clinical stuff of the facility for signs of infection during the entire period. Monthly CT angioscans checked 
for fractures and ‘vascualr patency’.
imaging and histological analyses. To monitor bone regeneration, CT angiscan were taken at day 0 
(post-operative), 30, 60 and 90 using the same parameters as described for the pre-operative phase. After com-
pleting the CT scans at day 90, metatarsis were harvested and fixed in 4% formalin for 2 weeks at room tempera-
ture (Roti®-Histofix 4%, Carl Roth, France).
To obtain high-resolution images of the metatarsus at the endpoint of the study, explants were scanned 
using an in vivo cone-beam micro-computed tomography (microCT) scanner (Skyscan 1076, Bruker, Kontich, 
Belgium) during the fixation period. The X-ray tube was operated at 50 kV and 200 µA. Scans were recorded with 
1° rotation step over 180° and exposure of 400 ms giving a resolution of 18 µm per pixel. The 3D reconstruction 
was performed using the accompanying software NRecon (Bruker, Kontich, Belgium). The percentage of bone 
volume + material volume over total volume (BV + MV/TV) was calculated in the selected region of interest cor-
responding to the diaphyseal defect and compared to the microCT of the 3D scaffold taken before implantation 
by the Skysan CT Analyzer (CTAn) software.
For histological examination, fixed samples were dehydrated in ascending grades of ethanol, immersed in 
xylol (Carl Roth) as intermedium and embedded in methyl methacrylate (Sigma Aldrich). Undecalcified thin 
ground sections were prepared in the longitudinal plane using the EXAKT cutting and grinding equipment 
(EXAKT Advanced Technologies, Norderstedt, Germany) according to the method established by Donath49. The 
sections were reduced to a thickness of 60 µm and stained with Levai-Laczko dye to differentiate between new 
bone, old bone and the 3D-printed scaffold50. For descriptive histological evaluation, the slides were scanned 
using an Olympus VS120 virtual slide microscope (Olympus, Tokyo, Japan) with a 20x objective.
Statistical data analysis. Measurements of struts and pores sizes of the 3D scaffolds were performed using 
20 readings on 3 different scaffolds. Mercury porosimetry, specific surface area and phase composition by XRD 
were determined on 3 samples. Compressive strength was measured on standard cylinders (n = 10/group). Data 
were expressed as average ± standard deviation. Since this is a pilot study with a limited number of animals, com-
parison between groups could not be performed. Data were graphed with GraphPad Prism software (GraphPad 
Software Inc., La Jolla, USA).
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